Feb. 23, 2024 Price forecast | 2 weeks: -3.02% | 1 month: -5.95% | 3 months: -7.03%


KALV stock forecast

Our latest prediction for KalVista Pharmaceuticals Inc's stock price was made on the Feb. 23, 2024 when the stock price was at 12.58$.

In the short term (2weeks), KALV's stock price should underperform the market by -3.02%. During that period the price should oscillate between -16.60% and +10.71%.

In the medium term (3months), KALV's stock price should underperform the market by -7.03%. During that period the price should oscillate between -46.46% and +22.10%.

Create a solid portfolio with KALV

Add KALV to your portfolio and optimize it!


About KalVista Pharmaceuticals Inc

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.

At the moment the company generates 13M USD in revenues.

On its last earning announcement, the company reported a loss of -3.03$ per share.

The book value per share is 1.53$

KalVista Pharmaceuticals Inc website


Three months stock forecastFeb. 23, 2024


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
13M - -117M - -97M -3.03 - - 34M 1.53 - - -